Systems level immune response analysis and personalized medicine

The immune system is an anatomically structured, orchestrated interaction of different cell types that communicate via a large number of receptors recognizing both soluble and cellular ligands. Recent technological advances now allow large-scale measurements for better appreciation of this complexity. Despite these advances, only a few immunological parameters are routinely measured in clinical practice. The authors believe that these measurements are insufficient to describe the immune function of individual patients and thus cannot be used to evaluate immune-mediated diseases or response to therapy. Our current knowledge of immunology comes largely from work in murine model systems where the immune system has been characterized in great detail. This impressive volume of knowledge has proven to be difficult to translate into novel therapies in humans; one reason for this is the lack of large-scale immune monitoring allowing for systems-wide analysis of the human immune system. The authors propose a systems approach to immunology, where the focus is moved from analysis of individual cell types towards more integrated studies of the entire immune system. Exercising ‘systems immunology’ in preclinical research, during drug development and in patients undergoing therapies affecting the immune system, will enable us to improve clinical results through personalized medicine and help to define clinically relevant patterns of immune reactivity.

[1]  Sean C. Bendall,et al.  A deep profiler's guide to cytometry. , 2012, Trends in immunology.

[2]  C. Huttenhower,et al.  Metagenomic microbial community profiling using unique clade-specific marker genes , 2012, Nature Methods.

[3]  Katherine H. Huang,et al.  A framework for human microbiome research , 2012, Nature.

[4]  J. Andersson,et al.  Local immune responses in human tuberculosis: learning from the site of infection. , 2012, The Journal of infectious diseases.

[5]  M. Partinen,et al.  Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland , 2012, PloS one.

[6]  S. Himanen,et al.  AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland , 2012, PloS one.

[7]  J. Clemente,et al.  Human gut microbiome viewed across age and geography , 2012, Nature.

[8]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[9]  Mark M. Davis,et al.  Significance analysis of xMap cytokine bead arrays , 2012, Proceedings of the National Academy of Sciences.

[10]  Sean C. Bendall,et al.  Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. , 2012, Immunity.

[11]  P. Caramelli,et al.  Narcolepsy after A/H1N1 vaccination , 2012, Clinics.

[12]  F. Di Virgilio,et al.  Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice , 2011, Science.

[13]  Zhigang Tian,et al.  Defining the critical hurdles in cancer immunotherapy , 2011, Journal of Translational Medicine.

[14]  S. Galli,et al.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils , 2011, Nature Immunology.

[15]  Eva K. Lee,et al.  Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.

[16]  Mark M. Davis,et al.  Interrogating the repertoire: broadening the scope of peptide–MHC multimer analysis , 2011, Nature Reviews Immunology.

[17]  Ya-Jen Chang,et al.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.

[18]  Keji Zhao,et al.  Application of ChIP-Seq and related techniques to the study of immune function. , 2011, Immunity.

[19]  Sean C. Bendall,et al.  Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.

[20]  S. Henson,et al.  Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? , 2011, Nature Reviews Immunology.

[21]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[22]  L. Hood,et al.  Predictive, personalized, preventive, participatory (P4) cancer medicine , 2011, Nature Reviews Clinical Oncology.

[23]  J. O’Shea,et al.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 , 2011, Nature Immunology.

[24]  J. Henter,et al.  Cytotoxic therapy for severe swine flu A/H1N1 , 2010, The Lancet.

[25]  Jeff E. Mold,et al.  Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans , 2010, Science.

[26]  F. Marincola,et al.  Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force , 2010, Journal of Translational Medicine.

[27]  Patrick F. Sullivan,et al.  LifeGene—a large prospective population-based study of global relevance , 2010, European Journal of Epidemiology.

[28]  A. Desautels,et al.  Post-H1N1 narcolepsy-cataplexy. , 2010, Sleep.

[29]  M. Maeurer,et al.  Humoral 'reactome' profiles using peptide microarray chips. , 2010, Trends in immunology.

[30]  Peter H. Sudmant,et al.  Diversity of Human Copy Number Variation and Multicopy Genes , 2010, Science.

[31]  T. Ideker,et al.  A decade of systems biology. , 2010, Annual review of cell and developmental biology.

[32]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[33]  Dmitry Bandura,et al.  Highly multiparametric analysis by mass cytometry. , 2010, Journal of immunological methods.

[34]  M. Maeurer.  Markus Maeurer on the LifeGene project , 2010, Expert review of clinical immunology.

[35]  Sebastiaan Overeem,et al.  Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy , 2010, Nature Genetics.

[36]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[37]  K. Tokunaga,et al.  Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. , 2010, Sleep.

[38]  V. Pascual,et al.  Assessing the human immune system through blood transcriptomics , 2010, BMC Biology.

[39]  T. Giese,et al.  Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer , 2010, Cancer Immunology, Immunotherapy.

[40]  M. Mühlethaler,et al.  Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. , 2010, The Journal of clinical investigation.

[41]  T. Tumpey,et al.  Pathogenesis of Pandemic Influenza A (H1N1) and Triple-Reassortant Swine Influenza A (H1) Viruses in Mice , 2010, Journal of Virology.

[42]  R. Medzhitov,et al.  Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. , 2010, Cell host & microbe.

[43]  Bin Cao,et al.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. , 2009, The New England journal of medicine.

[44]  J. Harty,et al.  Tracking the Total CD8 T Cell Response to Infection Reveals Substantial Discordance in Magnitude and Kinetics between Inbred and Outbred Hosts1 , 2009, The Journal of Immunology.

[45]  R. Perez-Padilla,et al.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. , 2009, The New England journal of medicine.

[46]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[47]  N. Hacohen,et al.  A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection , 2009, Cell.

[48]  C. Mohan,et al.  Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire. , 2009, Molecular immunology.

[49]  A. Aseffa,et al.  Immunopathology and Infectious Diseases Compartmentalization of Immune Responses in Human Tuberculosis Few CD 8 Effector T Cells but Elevated Levels of FoxP 3 Regulatory T Cells in the Granulomatous Lesions , 2010 .

[50]  C. Gieger,et al.  Narcolepsy is strongly associated with the TCR alpha locus , 2009, Nature Genetics.

[51]  S. Friend,et al.  A network view of disease and compound screening , 2009, Nature Reviews Drug Discovery.

[52]  P. Brodin,et al.  NK cell education: not an on-off switch but a tunable rheostat. , 2009, Trends in immunology.

[53]  Mark M Davis,et al.  A prescription for human immunology. , 2008, Immunity.

[54]  M. Schutkowski,et al.  Pattern Recognition in Pulmonary Tuberculosis Defined by High Content Peptide Microarray Chip Analysis Representing 61 Proteins from M. tuberculosis , 2008, PloS one.

[55]  C. Petersson,et al.  Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. , 2008, Diabetes research and clinical practice.

[56]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[57]  A. Hayday,et al.  The habitual, diverse and surmountable obstacles to human immunology research , 2008, Nature Immunology.

[58]  S. O’Day,et al.  Targeting cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) , 2007, Cancer.

[59]  Silke Schmidt,et al.  Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.

[60]  H. Harbo,et al.  Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis , 2007, Nature Genetics.

[61]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[62]  J. Tuomilehto,et al.  A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996 , 2007, Diabetologia.

[63]  R. Wehrle,et al.  Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. , 2006, Archives of internal medicine.

[64]  K. Sugio,et al.  A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma , 2006, International journal of cancer.

[65]  Erik K. Malm,et al.  A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.

[66]  V. Pankratz,et al.  Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. , 2005, Sleep.

[67]  Jessica M Malenfant,et al.  CD107a as a functional marker for the identification of natural killer cell activity. , 2004, Journal of immunological methods.

[68]  I. Gut,et al.  Future potential of the Human Epigenome Project , 2004, Expert review of molecular diagnostics.

[69]  T. Scammell,et al.  Narcolepsy caused by acute disseminated encephalomyelitis. , 2004, Archives of neurology.

[70]  R. Tibshirani,et al.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. , 2004, The New England journal of medicine.

[71]  Peter O. Krutzik,et al.  Intracellular phospho‐protein staining techniques for flow cytometry: Monitoring single cell signaling events , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[72]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[73]  J. Sutcliffe,et al.  The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding , 2000, Journal of neuroscience research.

[74]  P. Openshaw,et al.  Flow cytometric measurement of intracellular cytokines. , 2000, Journal of immunological methods.

[75]  Michael Aldrich,et al.  Reduced Number of Hypocretin Neurons in Human Narcolepsy , 2000, Neuron.

[76]  Sebastiaan Overeem,et al.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.

[77]  Z. Grossman,et al.  Self-tolerance: context dependent tuning of T cell antigen recognition. , 2000, Seminars in immunology.

[78]  D. Jäger,et al.  Clonal expansion of melan a‐specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma‐associated peptides , 2000, International journal of cancer.

[79]  Yao-Tseng Chen.  Cancer vaccine: identification of human tumor antigens by SEREX. , 2000, Cancer journal.

[80]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[81]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[82]  D. Jäger,et al.  Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes , 1998, The Journal of experimental medicine.

[83]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[84]  Jürg Zimmermann,et al.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.

[85]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[86]  M. Serrano,et al.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.

[87]  J. Ilonen,et al.  A comparison of childhood and adult type I diabetes mellitus. , 1989, The New England journal of medicine.

[88]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[89]  B Roth,et al.  Life Effects of Narcolepsy in 180 Patients from North America, Asia and Europe Compared to Matched Controls , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[90]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[91]  B. Rovin,et al.  Of mice and men: The relevance of the mouse to the study of human SLE , 2001, Immunologic research.